Neil Sengupta to Ontario
This is a "connection" page, showing publications Neil Sengupta has written about Ontario.
Connection Strength
0.189
-
Higher vedolizumab serum levels do not increase the risk of adverse events in patients with inflammatory bowel disease. Scand J Gastroenterol. 2020 Jul; 55(7):800-805.
Score: 0.189
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.